A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
Clinical trial NCT03978520 · COMPLETED
Trial details
- NCT number
- NCT03978520
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-25
- Primary completion
- 2022-01-19
- Enrollment
- 341
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.